clinical trial · NCT06703463
A Drug-Drug Interaction Study of Diltiazem and MK-1167 in Healthy Adult Participants (MK-1167-006)
Merck Sharp & Dohme LLC·phase1·completed·n = 16
HealthyMK-1167Diltiazem
brief summary
The goal of this study this study is to learn about the safety of MK-1167 and if people tolerate it. Researchers will compare what happens to MK-1167 in the body when it is given with and without another medicine called diltiazem.
started
Oct 17, 2023
primary completion
Feb 2, 2024
completion
Feb 2, 2024
last updated
Nov 25, 2024
official title
A Phase 1, Open-Label, Fixed-Sequence Study to Evaluate the Effect of Multiple Doses of Diltiazem on the Single-Dose Pharmacokinetics of MK-1167 in Healthy Adult Participants
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol